1Laboratory of Immunology, Division of Therapeutic Proteins, Food and Drug Administration, Center for Biologics and Evaluation and Research, Bethesda, MD 20892, USA. wicknery@ninds.nih.gov
A serine protease inhibitor, N-tosyl-L-lysine chloromethyl ketone (TLCK), enhances Fas-mediated apoptosis in resistant cells. This enhancement is specific to Fas-induced cell death and inversely correlates with Fas aggregation.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: